Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

PHASE2RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 21, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

February 28, 2025

Conditions
Atopic Dermatitis
Interventions
DRUG

Placebo

Placebo Comparator

DRUG

ASLAN004

ASLAN004

Trial Locations (27)

14051

RECRUITING

ASLAN Investigative Site, East Amherst

28277

RECRUITING

ASLAN Investigative Site, Charlotte

29407

RECRUITING

ASLAN Investigative Site, Charleston

32080

RECRUITING

ASLAN Investigative Site, Saint Augustine

32720

RECRUITING

ASLAN Investigative Site, Orange City

33014

RECRUITING

ASLAN Investigative Site, Miami Lakes

33021

RECRUITING

ASLAN Investigative Site, Hollywood

33162

RECRUITING

ASLAN Investigative Site, North Miami Beach

33436

RECRUITING

ASLAN Investigative Site, Hollywood

33486

RECRUITING

ASLAN Investigative Site, Boca Raton

33705

RECRUITING

ASLAN Investigative Site, St. Petersburg

35244

RECRUITING

ASLAN Investigative Site, Birmingham

40217

RECRUITING

ASLAN Investigative Site, Louisville

47150

RECRUITING

ASLAN Investigative Site, New Albany

48326

RECRUITING

ASLAN Investigative Site, Auburn Hills

73118

RECRUITING

ASLAN Investigative Site, Oklahoma City

89148

RECRUITING

ASLAN Investigative Site, Las Vegas

90025

RECRUITING

ASLAN Investigative Site, Los Angeles

90806

RECRUITING

ASLAN Investigative Site, Long Beach

91403

RECRUITING

ASLAN Investigative Site, Sherman Oaks

91436

RECRUITING

ASLAN Investigative Site, Encino

92708

RECRUITING

ASLAN Investigative Site, Fountain Valley

02169

RECRUITING

ASLAN Investigative Site, Quincy

02919

RECRUITING

ASLAN Investigative Site, Johnston

L8LCC3

RECRUITING

ASLAN Investigative Site, Hamilton

K1H1E4

RECRUITING

ASLAN Investigative Site, Ottawa

Unknown

RECRUITING

ASLAN Investigative Site, Toronto

Sponsors
All Listed Sponsors
lead

ASLAN Pharmaceuticals

OTHER